Department of Pediatrics, Seattle Children's Hospital and University of Washington, Seattle, WA, USA.
Pediatr Blood Cancer. 2013 Jan;60(1):110-5. doi: 10.1002/pbc.24198. Epub 2012 May 24.
The differential effects of cranial radiotherapy (CRT), spinal radiotherapy (SRT), and total body irradiation (TBI) on growth and endocrine outcomes have rarely been examined in combination among childhood acute leukemia survivors.
Self-reported height/weight, hypothyroidism, and pregnancy/live birth were determined among acute lymphoblastic and myeloid leukemia survivors (n = 3,467) participating in the Childhood Cancer Survivor Study, an ongoing cohort study of 5-year survivors of pediatric cancers diagnosed from 1970 to 1986.
Compared with no radiotherapy, risk estimates were consistent across outcomes (adult short stature, hypothyroidism, absence of pregnancy/live birth) with CRT treatment associated with 2-3-fold increased risks, TBI associated with 5-10 fold increased risks, and CRT + TBI associated with >10 fold increased risks. Exposure to any SRT further increased risk of these outcomes 2-3-fold. Changes in body composition were more nuanced as CRT only was associated with an increased risk of being overweight/obese (OR 1.6, 95% CI 1.3-1.9) whereas TBI only was associated with an increased risk of being underweight (OR 6.0, 95% CI 2.4-14.9).
Although patients treated with CRT + TBI were at greatest risk for short stature, hypothyroidism, and a reduced likelihood of pregnancy/live birth, those treated with either modality alone had significantly increased risks as well, including altered body composition. Any SRT exposure further increased risk in an independent fashion.
颅放疗(CRT)、脊柱放疗(SRT)和全身放疗(TBI)对儿童急性白血病幸存者的生长和内分泌结果的影响差异很少被联合研究。
通过自我报告的身高/体重、甲状腺功能减退症和妊娠/活产情况,对参加儿童癌症幸存者研究的急性淋巴细胞白血病和髓样白血病幸存者(n=3467)进行了评估。该研究是一项正在进行的队列研究,研究对象为 1970 年至 1986 年期间诊断出的儿科癌症 5 年幸存者。
与无放疗相比,CRT 治疗与成人身材矮小、甲状腺功能减退症、无妊娠/活产等结局相关的风险估计值一致,风险增加 2-3 倍,TBI 相关风险增加 5-10 倍,CRT+TBI 相关风险增加 >10 倍。任何 SRT 的暴露进一步增加了这些结局的风险 2-3 倍。身体成分的变化更为微妙,因为 CRT 仅与超重/肥胖的风险增加相关(OR 1.6,95%CI 1.3-1.9),而 TBI 仅与体重不足的风险增加相关(OR 6.0,95%CI 2.4-14.9)。
尽管接受 CRT+TBI 治疗的患者身材矮小、甲状腺功能减退症和妊娠/活产的可能性降低的风险最高,但单独接受任一治疗的患者也存在显著增加的风险,包括身体成分改变。任何 SRT 的暴露都会以独立的方式进一步增加风险。